Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.510
+0.050 (1.45%)
At close: Mar 9, 2026, 4:00 PM EDT
3.450
-0.060 (-1.71%)
After-hours: Mar 9, 2026, 7:58 PM EDT

Recursion Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Cash & Equivalents
743.29594.35391.57549.91285.12
Upgrade
Short-Term Investments
----231.45
Upgrade
Cash & Short-Term Investments
743.29594.35391.57549.91516.56
Upgrade
Cash Growth
25.06%51.79%-28.79%6.46%97.07%
Upgrade
Accounts Receivable
----0.03
Upgrade
Other Receivables
24.6549.173.092.759.06
Upgrade
Receivables
24.6549.173.092.759.09
Upgrade
Prepaid Expenses
11.7429.6---
Upgrade
Restricted Cash
4.593.053.231.281.55
Upgrade
Other Current Assets
28.5738.1140.2515.877.51
Upgrade
Total Current Assets
812.85714.27438.14569.81534.72
Upgrade
Property, Plant & Equipment
169.48233.21120.17121.4564.73
Upgrade
Long-Term Investments
4.4----
Upgrade
Goodwill
162.16148.8752.060.80.8
Upgrade
Other Intangible Assets
309.9335.8636.441.311.39
Upgrade
Long-Term Deferred Tax Assets
0.961.93---
Upgrade
Other Long-Term Assets
14.3914.456.897.928.72
Upgrade
Total Assets
1,4741,449653.7701.29610.35
Upgrade
Accounts Payable
18.1221.613.954.592.82
Upgrade
Accrued Expenses
69.5380.2841.7630.2927.67
Upgrade
Current Portion of Long-Term Debt
0.120.110.040.10.09
Upgrade
Current Portion of Leases
21.6322.116.125.95-
Upgrade
Current Unearned Revenue
37.6161.7736.4356.7310
Upgrade
Other Current Liabilities
0.71.594.872.626.08
Upgrade
Total Current Liabilities
147.71187.4793.17100.2746.66
Upgrade
Long-Term Debt
0.190.681.10.540.63
Upgrade
Long-Term Leases
56.0285.5943.4144.42-
Upgrade
Long-Term Unearned Revenue
114.01118.7751.2470.266.67
Upgrade
Long-Term Deferred Tax Liabilities
23.2616.581.34--
Upgrade
Other Long-Term Liabilities
2.084.73--13.45
Upgrade
Total Liabilities
343.27413.82190.26215.4867.41
Upgrade
Common Stock
0.010000
Upgrade
Additional Paid-In Capital
3,1702,4741,4311,125943.14
Upgrade
Retained Earnings
-2,076-1,431-967.62-639.56-400.08
Upgrade
Comprehensive Income & Other
36.72-7.64---0.13
Upgrade
Total Common Equity
1,1311,035463.44485.81542.94
Upgrade
Shareholders' Equity
1,1311,035463.44485.81542.94
Upgrade
Total Liabilities & Equity
1,4741,449653.7701.29610.35
Upgrade
Total Debt
77.97108.4950.6751.010.72
Upgrade
Net Cash (Debt)
665.33485.86340.89498.91515.84
Upgrade
Net Cash Growth
36.94%42.52%-31.67%-3.28%106.63%
Upgrade
Net Cash Per Share
1.491.771.642.844.12
Upgrade
Filing Date Shares Outstanding
527.4401.99234.65191.23170.77
Upgrade
Total Common Shares Outstanding
528.18396.8234.27191.02170.27
Upgrade
Working Capital
665.14526.8344.97469.55488.06
Upgrade
Book Value Per Share
2.142.611.982.543.19
Upgrade
Tangible Book Value
658.8550.05374.94483.7540.75
Upgrade
Tangible Book Value Per Share
1.251.391.602.533.18
Upgrade
Machinery
121.86128.2982.2267.6953.08
Upgrade
Construction In Progress
0.512.713.238.7516.45
Upgrade
Leasehold Improvements
70.7872.7345.9341.8713.94
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.